SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Angeline Oi-Shan Lo, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Henry Lik-Yuen Chan, Yock-Young Dan, Cost Effectiveness of Response-Guided Therapy With Peginterferon in the Treatment of Chronic Hepatitis B, Clinical Gastroenterology and Hepatology, 2015, 13, 2, 377

    CrossRef

  2. 2
    Angeline Oi-Shan Lo, Grace Lai-Hung Wong, Current developments in nucleoside/nucleotide analogues for hepatitis B, Expert Review of Gastroenterology & Hepatology, 2014, 8, 6, 607

    CrossRef

  3. You have free access to this content3
    Maria Buti, HBeAg-positive chronic hepatitis B: Why do I treat my patients with Nucleos(t)ide Analogs?, Liver International, 2014, 34,
  4. 4
    George K. K. Lau, Interferon for Chinese patients with chronic hepatitis B e antigen-positive diseases—the controversy arises again?, Hepatology International, 2014, 8, 3, 301

    CrossRef

  5. You have free access to this content5
    JSH Guidelines for the Management of Hepatitis B Virus Infection, Hepatology Research, 2014, 44,
  6. 6
    Chien-Hung Chen, Sheng-Nan Lu, Chuan-Mo Lee, Chao-Hung Hung, Jing-Houng Wang, Tsung-Hui Hu, Patients with interferon-induced HBeAg seroconversion have a higher risk of HBV reactivation and HBeAg seroreversion, Hepatology International, 2014, 8, 3, 365

    CrossRef

  7. 7
    Patrick Miailhes, Marianne Maynard-Muet, Fanny Lebossé, Fabrice Carrat, Cécile Bouix, Caroline Lascoux-Combe, Philippe Sogni, David Rey, Yoann Barthe, Stanislas Pol, Patrice Cacoub, Fabien Zoulim, Lionel Piroth, Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-co-infected patients on cART including tenofovir: EMVIPEG study, Journal of Hepatology, 2014, 61, 4, 761

    CrossRef

  8. 8
    Rama Kapoor, Shyam Kottilil, Strategies to eliminate HBV infection, Future Virology, 2014, 9, 6, 565

    CrossRef

  9. 9
    Yuan Tian, Vincent Wai-Sun Wong, Henry Lik-Yuen Chan, Alfred Sze-Lok Cheng, Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease, Seminars in Cancer Biology, 2013, 23, 6, 471

    CrossRef

  10. 10
    Milan J. Sonneveld, Vincent Rijckborst, Louwerens Zwang, Stefan Zeuzem, E. Jenny Heathcote, Krzysztof Simon, Roeland Zoutendijk, Ulus S. Akarca, Suzan D. Pas, Bettina E. Hansen, Harry L.A. Janssen, Hepatitis B e antigen levels and response to peginterferon: Influence of precore and basal core promoter mutants, Antiviral Research, 2013, 97, 3, 312

    CrossRef

  11. 11
    Teerha Piratvisuth, Patrick Marcellin, Matei Popescu, Hans-Peter Kapprell, Vivien Rothe, Zhi-Meng Lu, Hepatitis B surface antigen: association with sustained response to peginterferon alfa-2a in hepatitis B e antigen-positive patients, Hepatology International, 2013, 7, 2, 429

    CrossRef

  12. 12
    W.-K. Seto, D. K.-H. Wong, M. Kopaniszen, P. Proitsi, P.-C. Sham, I. F.-N. Hung, J. Fung, C.-L. Lai, M.-F. Yuen, HLA-DP and IL28B Polymorphisms: Influence of Host Genome on Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B, Clinical Infectious Diseases, 2013, 56, 12, 1695

    CrossRef

  13. 13
    Yun-Fan Liaw, Impact of Therapy on the Long-Term Outcome of Chronic Hepatitis B, Clinics in Liver Disease, 2013, 17, 3, 413

    CrossRef

  14. You have free access to this content14
    Yun-Fan Liaw, Impact of therapy on the outcome of chronic hepatitis B, Liver International, 2013, 33,
  15. 15
    Geoffrey C. Farrell, Vincent Wai-Sun Wong, Shiv Chitturi, NAFLD in Asia—as common and important as in the West, Nature Reviews Gastroenterology & Hepatology, 2013, 10, 5, 307

    CrossRef

  16. 16
    Laurent Castera, Valérie Vilgrain, Paul Angulo, Noninvasive evaluation of NAFLD, Nature Reviews Gastroenterology & Hepatology, 2013, 10, 11, 666

    CrossRef

  17. 17
    Elisabetta Degasperi, Mauro Viganò, Alessio Aghemo, Pietro Lampertico, Massimo Colombo, PegIFN-α2a for the treatment of chronic hepatitis B and C: a 10-year history, Expert Review of Anti-infective Therapy, 2013, 11, 5, 459

    CrossRef

  18. 18
    Qiang Wei, Xiao Xu, Qi Ling, Bo Zhou, Shu-Sen Zheng, Perioperative antiviral therapy for chronic hepatitis B-related hepatocellular carcinoma, Hepatobiliary & Pancreatic Diseases International, 2013, 12, 3, 251

    CrossRef

  19. 19
    R. Zoutendijk, M. J. Sonneveld, J. G. P. Reijnders, A. J. Vuuren, P. Biesta, B. E. Hansen, A. Boonstra, H. L. A. Janssen, Precore and core promoter mutants are associated with higher HBeAg seroconversion but low disease remission rates in HBV patients treated with nucleos(t)ide analogues, Journal of Viral Hepatitis, 2013, 20, 5
  20. 20
    Milan J. Sonneveld, Bettina E. Hansen, Teerha Piratvisuth, Ji-Dong Jia, Stefan Zeuzem, Edward Gane, Yun-Fan Liaw, Qing Xie, E. Jenny Heathcote, Henry L.-Y. Chan, Harry L.A. Janssen, Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levels, Hepatology, 2013, 58, 3
  21. 21
    Mauro Viganò, Giampaolo Mangia, Pietro Lampertico, Results of Treatment of Chronic Hepatitis B with Pegylated Interferon, Clinics in Liver Disease, 2013, 17, 3, 425

    CrossRef

  22. 22
    Grace Lai-Hung Wong, Ching-Ning Chong, Vincent Wai-Sun Wong, Tertiary Prevention of HBV-related HCC in Asia, Current Hepatitis Reports, 2013, 12, 3, 157

    CrossRef

  23. 23
    Yun-Fan Liaw, Jia-Horng Kao, Teerha Piratvisuth, Henry Lik Yuen Chan, Rong-Nan Chien, Chun-Jen Liu, Ed Gane, Stephen Locarnini, Seng-Gee Lim, Kwang-Hyub Han, Deepak Amarapurkar, Graham Cooksley, Wasim Jafri, Rosmawati Mohamed, Jin-Lin Hou, Wan-Long Chuang, Laurentius A. Lesmana, Jose D. Sollano, Dong-Jin Suh, Masao Omata, Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update, Hepatology International, 2012, 6, 3, 531

    CrossRef

  24. 24
    Vincent Wai-Sun Wong, Joseph Jao-Yiu Sung, Diagnosis and personalized management of hepatitis B including significance of genotypes, Current Opinion in Infectious Diseases, 2012, 25, 5, 570

    CrossRef

  25. 25
    Steven J. Scaglione, Anna S.F. Lok, Effectiveness of Hepatitis B Treatment in Clinical Practice, Gastroenterology, 2012, 142, 6, 1360

    CrossRef

  26. 26
    Kevin T. Chaung, Nghiem B. Ha, Huy N. Trinh, Ruel T. Garcia, Huy A. Nguyen, Khanh K. Nguyen, Gabriel Garcia, Aijaz Ahmed, Emmet B. Keeffe, Mindie H. Nguyen, High Frequency of Recurrent Viremia After Hepatitis B e Antigen Seroconversion and Consolidation Therapy, Journal of Clinical Gastroenterology, 2012, 46, 10, 865

    CrossRef

  27. 27
    Vincent Wai-Sun Wong, Julien Vergniol, Grace Lai-Hung Wong, Juliette Foucher, Anthony Wing-Hung Chan, Faiza Chermak, Paul Cheung-Lung Choi, Wassil Merrouche, Shirley Ho-Ting Chu, Sophie Pesque, Henry Lik-Yuen Chan, Victor de Lédinghen, Liver Stiffness Measurement Using XL Probe in Patients With Nonalcoholic Fatty Liver Disease, The American Journal of Gastroenterology, 2012, 107, 12, 1862

    CrossRef

  28. 28
    Milan J. Sonneveld, Vincent W.–S. Wong, Andrea M. Woltman, Grace L.H. Wong, Yilmaz Cakaloglu, Stefan Zeuzem, Erik H.C.J. Buster, Andre G. Uitterlinden, Bettina E. Hansen, Henry L.Y. Chan, Harry L.A. Janssen, Polymorphisms Near IL28B and Serologic Response to Peginterferon in HBeAg-Positive Patients With Chronic Hepatitis B, Gastroenterology, 2012, 142, 3, 513

    CrossRef

  29. 29
    Milan J. Sonneveld, Vincent Rijckborst, Stefan Zeuzem, E. Jenny Heathcote, Krzysztof Simon, Hakan Senturk, Suzan D. Pas, Bettina E. Hansen, Harry L.A. Janssen, Presence of precore and core promoter mutants limits the probability of response to peginterferon in hepatitis B e antigen-positive chronic hepatitis B, Hepatology, 2012, 56, 1
  30. 30
    Henry Lik-Yuen Chan, Response-guided therapy by hepatitis B surface antigen level for peginterferon therapy: What is next?, Journal of Gastroenterology and Hepatology, 2012, 27, 3
  31. 31
    Ben X. Wang, Eleanor N. Fish, The yin and yang of viruses and interferons, Trends in Immunology, 2012, 33, 4, 190

    CrossRef

  32. 32
    Yuk-Fai Lam, Man-Fung Yuen, Wai-Kay Seto, Ching-Lung Lai, Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and Safety, Current Hepatitis Reports, 2011, 10, 4, 235

    CrossRef

  33. 33
    M. J. Sonneveld, R. Zoutendijk, H. L. A. Janssen, Hepatitis B surface antigen monitoring and management of chronic hepatitis B, Journal of Viral Hepatitis, 2011, 18, 7
  34. 34
    Henry Lik-Yuen Chan, Alex Thompson, Michelle Martinot-Peignoux, Teerha Piratvisuth, Markus Cornberg, Maurizia Rossana Brunetto, Hans L. Tillmann, Jia-Horng Kao, Ji-Dong Jia, Heiner Wedemeyer, Stephen Locarnini, Harry L.A. Janssen, Patrick Marcellin, Hepatitis B surface antigen quantification: Why and how to use it in 2011 – A core group report, Journal of Hepatology, 2011, 55, 5, 1121

    CrossRef

  35. 35
    Michael Chang, Sammy Saab, Interferon for Hepatitis B: Which Populations Benefit the Most, Current Hepatitis Reports, 2011, 10, 4, 285

    CrossRef

  36. 36
    Yoo-Kyung Cho, Byung-Cheol Song, New Insight for HBV DNA and HBsAg Quantitation during Antiviral Therapy in Patients with Chronic Hepatitis B, The Korean Journal of Gastroenterology, 2011, 57, 3, 144

    CrossRef

  37. 37
    Y. Liang, J. Jiang, M. Su, Z. Liu, W. Guo, X. Huang, R. Xie, S. Ge, J. Hu, Z. Jiang, M. Zhu, V. W.-S. Wong, H. L.-Y. Chan, Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy, Alimentary Pharmacology & Therapeutics, 2011, 34, 3
  38. 38
    James Fung, Ching-Lung Lai, Man-Fung Yuen, To stop or not to stop: The quest for long-term viral suppression, Journal of Gastroenterology and Hepatology, 2011, 26, 3
  39. 39
    G. L.-H. Wong, K. K.-L. Yiu, V. W.-S. Wong, K. K.-F. Tsoi, H. L.-Y. Chan, Meta-analysis: reduction in hepatic events following interferon-alfa therapy of chronic hepatitis B, Alimentary Pharmacology & Therapeutics, 2010, 32, 9
  40. 40
    H. L.-Y. Chan, V. W.-S. Wong, A. M.-L. Chim, H.-Y. Chan, G. L.-H. Wong, J. J.-Y. Sung, Serum HBsAg quantification to predict response to peginterferon therapy of e antigen positive chronic hepatitis B, Alimentary Pharmacology & Therapeutics, 2010, 32, 11-12
  41. 41
    Vincent Wai-Sun Wong, Henry Lik-Yuen Chan, Transient elastography, Journal of Gastroenterology and Hepatology, 2010, 25, 11